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TECHNICAL NOTEWavelet-Based Angiographic Reconstruction of
Computed Tomography Perfusion Data
Diagnostic Value in Cerebral Venous Sinus ThrombosisWolfgang G. Kunz, MD,* Felix Schuler,* Wieland H. Sommer, MD, MPH,* Matthias P. Fabritius, MD,*
Lukas Havla, PhD,† Felix G. Meinel, MD,* Maximilian F. Reiser, MD,*
Birgit Ertl-Wagner, MD, MHBA,* and Kolja M. Thierfelder, MD, MSc*Objective:The aim of this studywas to test the diagnostic value of wavelet-based
angiographic reconstruction of CT perfusion data (waveletCTA) to detect cerebral
venous sinus thrombosis (CVST) in patients who underwent whole-brain
CT perfusion imaging (WB-CTP).
Materials and Methods: Datasets were retrospectively selected from an initial
cohort of 2863 consecutive patients who had undergone multiparametric CT
including WB-CTP. WaveletCTAwas reconstructed fromWB-CTP: the angio-
graphic signal was generated by voxel-based wavelet transform of time attenuation
curves (TACs) from WB-CTP raw data. In a preliminary clinical evaluation,
waveletCTA was analyzed by 2 readers with respect to presence and location of
CVST. Venous CT and MR angiography (venCTA/venMRA) served as reference
standard. Diagnostic confidence for CVST detection and the quality of depiction
for venous sections were evaluated on 5-point Likert scales. Thrombus extent
was assessed by length measurements. The mean CT attenuation and waveletCTA
signal of the thrombus and of flowing blood were quantified.
Results: Sixteen patients were included: 10 patients with venCTA-/venMRA-
confirmed CVST and 6 patients with arterial single-phase CT angiography
(artCTA)–suspected but follow-up-excluded CVST. The reconstruction of waveletCTA
was successful in all patients. Among the patients with confirmed CVST,
waveletCTA correctly demonstrated presence, location, and extent of the thrombosis
in 10/10 cases. In 6 patients with artCTA-suspected but follow-up–excluded CVST,
waveletCTA correctly ruled out CVST in 5 patients. ReadingwaveletCTA in addition
to artCTA significantly increased the diagnostic confidence concerning CVST com-
pared with reading artCTA alone (4.4 vs 3.6, P = 0.044). The mean flowing
blood-to-thrombus ratio was highest in waveletCTA, followed by venCTA and
artCTA (146.2 vs 5.9 vs 2.6, each with P < 0.001). In waveletCTA, the venous
sections were depicted better compared with artCTA (4.2 vs 2.6, P < 0.001),
and equally well compared with venCTA/venMRA (4.2 vs 4.1, P = 0.374).
Conclusions: WaveletCTA was technically feasible in CVST patients and reli-
ably identified CVST in a preliminary clinical evaluation. WaveletCTA might
serve as an additional reconstruction to rule out or incidentally detect CVST in
patients who undergo WB-CTP.
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Copyright © 2017 Wolters Kluwer HC erebral venous sinus thrombosis (CVST) is a rare but importantdifferential diagnosis in patients with suspected ischemic stroke.
Cerebral venous sinus thrombosis is detected in 0.5% to 1.0% of acute
strokes.1 It can manifest with a wide variety of clinical symptoms.
Depending on the location of the thrombosis, patients can present
with signs of intracranial hypertension, headaches, aphasia, hemiparesis,
seizures, and disorientation.2,3
Most of the CVST symptoms can also be caused by ischemic
stroke, which is by far the more frequent diagnosis.4 Because of this
overlap of symptoms, CVST patients may undergo a multiparametric
stroke CT protocol including nonenhanced CT (NECT), arterial single-
phase CT angiography (artCTA), and dynamic CT perfusion (CTP).
Because standardized stroke protocols are generally not tailored to the
demonstration of venous vessels, the confirmation or exclusion of
CVST is frequently not possible in these examinations.
Abnormalities on NECT can only be seen in approximately 30%
of CVST patients,5 and artCTA can only demonstrate a filling defect in
cerebral sinuses when there is venous contamination. A further
challenge is the frequency of anatomical variations such as sinus
hypoplasia or aplasia.5 Hence, additional venous CT angiography
(venCTA) or MR angiography (venMRA)6 is often required to confirm
or rule out the diagnosis of CVST. Performing these examinations may
lead to a significant delay in diagnosis, which has shown to increase the
risk of a poor outcome.7 The additional screening also implies further
costs and may require a secondary administration of contrast agents
and/or radiation exposure of patients.
Novel postprocessing algorithms, however, can create high-
quality CT angiographies from the initially acquired CTP data.8–12
As CTP is a dynamic examination, it does not only cover the arterial
but also the venous phase, which implies the potential of these CTP-
derived angiographic techniques to detect CVST better than artCTA.13
Among these approaches, wavelet-transformed CTA (waveletCTA) has
shown an excellent signal-to-noise ratio14 and the ability to accurately
differentiate between arterial and venous vessels.13 The wavelet
transform generates the angiographic signal by voxel-based application
on time attenuation curves (TACs) from CTP raw data. Given that CTP
is part of the stroke protocol in clinical practice, the assessment of
CVSTusing waveletCTAwould be possible in a “1-stop shop” fashion
without any additional examinations.
The aim of the present study was to test the technical feasibility
and the diagnostic value of waveletCTA in a preliminary clinical
analysis in patients with confirmed or suspected CVST.MATERIALS AND METHODS
Study Design and Population
The institutional review board approved this retrospective
study and waived requirement for informed consent. Based on a
prospectively collected stroke registry, our initial cohort consisted
of 2863 consecutive patients who had undergone multiparametricInvestigative Radiology • Volume 52, Number 5, May 2017
ealth, Inc. All rights reserved.
FIGURE 1. Wavelet-based angiographic reconstruction of CT perfusion data. Schematic representation of wavelet-based angiographic reconstruction
of WB-CTP data. Voxel-basedwavelet transform of TACs produces a flow-sensitive representation ofWB-CTP data. The TAC and the generated wavelet
power spectrum are depicted for an M3 segment of the middle cerebral artery (red arrow), brain parenchyma (yellow arrow), and the superior
sagittal sinus (blue arrow), illustrating the differential signal generation.
Investigative Radiology • Volume 52, Number 5, May 2017 Wavelet-Based CTA for the Detection of CVSTCT protocol including whole-brain CT perfusion (WB-CTP) between
March 2009 and May 2016.
Of this cohort, we included all subjects with (1) evidence of
CVST confirmed by venCTA or venMRA with prior WB-CTP
(n = 12) or (2) suspected CVST on artCTA with subsequent negative
venCTA or venMRA (n = 7).TABLE 1. Patient Characteristics of the Study Population
Age Sex Underlying Disease Indication for WB-CTP
Follow-up–confirmed CVST
62 F Intracranial aneurysms Hemiparesis
82 F Acute ischemic stroke Motor aphasia
65 F Intracranial meningioma Motor aphasia
72 F Intracranial meningioma Hemiparesis
63 F Metastatic breast cancer Hemiparesis
74 F Cryptogenic liver cirrhosis Loss of consciousness
69 M CUP syndrome Motor aphasia
77 M Acute ischemic stroke Hemiparesis
46 M Metastatic melanoma Loss of consciousness
72 M Acute ischemic stroke Hemiparesis
ArtCTA-suspected but follow-up–excluded CVST
66 M Acute ischemic stroke Hemiparesis
61 F Myocardial infarction Hemiparesis
64 F Acute ischemic stroke Hemiparesis and aphasia
65 F Intracranial meningioma Hemiparesis
69 F Hepatic encephalopathy Hemiparesis
60 M Polytrauma Hemiparesis
*Additional venCTA imaging was performed right after WB-CTP to evaluate CVS
WB-CTP indicates whole-brain CT Perfusion; CVST, cerebral venous sinus throm
CUP, cancer of unknown primary; artCTA, arterial CT angiography; NA, not applicab
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer HWe excluded patients with (1) incomplete WB-CTP raw data
sets (n = 3) and (2) nondiagnostic quality of CT perfusion or
artCTA (n = 0).
As control population, 30 patients with both unremarkable initial
multiparametric CTand negative follow-upMRI were selected from the
initial cohort in a consecutive fashion.CVST
Standard
of Reference
Time From CTP to
Final Diagnosis Etiology
Yes VenCTA 19 h Postop
Yes VenMRA 44 h Unknown
Yes VenCTA 47 h Postop
Yes VenCTA VenCTA added* Postop
Yes VenCTA VenCTA added* Malignant
Yes VenCTA VenCTA added* Unknown
Yes VenCTA 216 h Malignant
Yes VenMRA 32 h Unknown
Yes VenCTA VenCTA added* Malignant
Yes VenCTA 165 h Unknown
No VenMRA 45 h NA
No VenMRA 12 h NA
No VenCTA 24 h NA
No VenMRA 71 h NA
No VenCTA VenCTA added* NA
No VenCTA 63 h NA
T due to clinical suspicion.
bosis; venCTA/venMRA, venous CT/MR angiography; F, female; M, male;
le.
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Kunz et al Investigative Radiology • Volume 52, Number 5, May 2017CT and MRI Examination Protocol
All patients underwent our standardized multiparametric CT
stroke imaging protocol consisting of NECT, artCTA, and WB-CTP.
All CT examinations were performed using 1 of the following 4 CT
scanners: SOMATOM Force, a 2  192 slice dual-source CT scanner;
SOMATOMDefinition Flash, a 2 128 slice dual-source CT scanner;
and SOMATOM Definition Edge and SOMATOM Definition AS+,
both 128 slice CT scanners (all Siemens Healthcare, Forchheim, Germany).
For artCTA, 50 mL of iodinated contrast agent was administered
intravenously, followed by a saline chaser of 40 mL, both with a flow
rate of 5 mL/s. Arterial CT angiography was performed from the aortic
arch to the vertex with 140 and 80 kV tube voltage and attenuation-
based tube current modulation (CareDose). Collimation was 0.6 mm.
Arterial CT angiography data were read as source images using syngo.
via imaging software (Siemens Healthcare, Forchheim, Germany).
Whole-brain CT perfusion imaging was obtained with 0.6 mm
collimation and 100 mm scan coverage in the z-axis using adaptive spi-
ral scanning. The data sets were acquired continuously over 48 seconds
(32 cycles, sweeps every 1.5 seconds). Tube voltage and current were
80 kVand 200 mA, respectively. CT dose index was 276 mGy. A total
of 35 mL of iodinated contrast agent (400 mg/mL) was administered at
a flow rate of 5 mL/s, followed by a saline flush of 40 mL at 5 mL/s.FIGURE 2. Example of waveletCTA-based confirmation of suspected CVST. A
cancer evaluated using multiparametric stroke CT for acute right-sided hemip
transverse sinus. B, On artCTA, the same sinus did not show any contrast enh
confirmed the diagnosis (arrow). D, WaveletCTA reconstruction would have c
304 www.investigativeradiology.com
Copyright © 2017 Wolters Kluwer HVenous CTangiography was performed with 60 mL of iodinated
contrast agent after a delay of 35 seconds using CareDose 4D and
attenuation-based tube current modulation (CareDose 4D); the other ac-
quisition parameters were the same as in artCTA. Contrast-enhanced
(CE) and time-of-flight (TOF) venMRA were performed on a 1.5 T
whole-body scanner (Siemens Aera, Siemens Healthcare, Erlangen,
Germany). For CE-venMRA, 0.1 mL of Gadovist per 1 kg body weight
(1.0 mmol/mL gadobutrol; Bayer Vital GmbH, Leverkusen, Germany)
was administered at a flow rate of 2 mL/s. Scanning was performed at a
delay of 35 seconds using a T1-weighted MRA sequence (repetition
time, 18.0 milliseconds; echo time, 4.03 milliseconds). Time-of-flight
venMRA was performed using axial and coronal planes with a slice
thickness of 2.5 mm, a repetition time of 25 milliseconds, and an echo
time of 6.92 milliseconds.
Image Postprocessing and Wavelet Transform
The 32  99 (phases  slices) CT DICOM images were
imported into in-house developed software (PMI, Platform for Medical
Imaging v0.4)15 based on IDL 8.3 (Exelis Visual Information Solutions,
Boulder, CO). On each 4-dimensional CT volume, rigid-body motion
correction was performed with the elastix toolbox16 using a binary
mask that contained all pixels with density > 0 HU at the first phase.63-year-old female patient with meningeal carcinomatosis from breast
aresis. A, NECT demonstrated a cord sign (arrowheads) along the left
ancement (arrow). C, VenCTA was additionally requested, which
onfirmed the diagnosis with equal diagnostic confidence (arrow).
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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Investigative Radiology • Volume 52, Number 5, May 2017 Wavelet-Based CTA for the Detection of CVSTThe main principle is to analyze the TAC of each voxel in terms
of its similarity to the shape of a generic and idealized contrast agent bo-
lus TAC. According to Havla et al,14 the complex-valued Paul wavelet
Ψ0(η) of order 1 serves the purposewell by visual resemblance between
the “analyzer”—the wavelet—and the “analyzed” data—the bolus
curves. The degrees of freedom such as translation (parameter t) and
scaling (parameter s) result in the “maximization of correlation” be-
tween TAC f(η) and the basis function (“mother wavelet”) at applying
the continuous wavelet transform:
Ψs;t ηð Þ ¼ sj j −1=2ð ÞΨ0 η− ts
 
f̃ s; tð Þ ¼ ∫f ηð ÞΨs;t ηð ÞdηwithΨs;t :¼ complexconjugateofΨs;t
This continuous wavelet transform results in a 2-dimensional function
called the wavelet power spectrum, of which the maximal value is
interpreted as angiographic signal intensity. The waveletCTA technique
provides a significantly improved contrast-to-noise ratio of arterial and
venous structures compared with temporal maximum intensity
projections and allows for the removal of bone structures such asFIGURE 3. Example of waveletCTA-based CVST diagnosis in negative multipa
hemiparesis. A and B, NECT and artCTA are unremarkable considering the cere
scans after 159 hours, incidental note was made of missing flow void (arrow)
another 6 hours by venCTA (arrow). E, WaveletCTA would have accurately ide
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer Hthe calvaria.14 An illustration of the waveletCTA generation is provided
in Figure 1.
Image Analysis of ArtCTA, VenCTA/VenMRA,
and WaveletCTA
Two readers, 1 board-certified attending radiologist (W.H.S.)
with over 10 years of experience in stroke imaging and one 5th-year
radiology resident (K.M.T.) with over 4 years of experience in stroke
imaging, independently evaluated initial NECT, artCTA, and WB-CTP
of 16 patients of the study population and 30 patients of the control
population in a randomized fashion. In case of disagreement, consensus
was reached in a separate session. Readers were blinded to clinical
information and follow-up imaging. The evaluation was performed
(1) in a first session without waveletCTA and (2) in a second session
(after 4 weeks) with additional access to waveletCTA.
In each session, the readers were asked to state their degree of
confidence in determining the pathology of CVST on a 5-point Likert
scale (1, nondiagnostic; 2, poor; 3, fair; 4, good; 5, excellent; rating:
“diagnostic confidence”). An artCTA-suspected CVSTwas defined if
the readers raised suspicion of CVST and recommended follow-up to
confirm or exclude. The quality of depiction of the dural venous sinusesrametric CT. A 72-year-old male patient examined for acute right-sided
bral veins and sinus (arrowheads). C, On the follow-up T2-weightedMRI
in the left transverse and sigmoid sinus. D, CVST was confirmed after
ntified the occluded sinus (arrow) in the initial examination.
www.investigativeradiology.com 305
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Kunz et al Investigative Radiology • Volume 52, Number 5, May 2017as well as the superficial and deep cerebral veins was rated on an
analogous 5-point Likert scale. Thrombus length was measured
using 3-dimensional reconstructions of data sets on the manufacturer's
imaging software (syngo.via CT Vascular; Siemens Healthcare,
Erlangen, Germany). In case that the thrombosis showed concom-
itant extracranial extension, the entry of the jugular foramen was
defined as the end point for measurements. Mean CT attenuation
(in Hounsfield units) and mean waveletCTA signal (dimensionless)
were quantified using circular regions of interest within the thrombus
and in the adjacent proximal sinus with normal perfusion (“flowing
blood”). Venous CT angiography and venMRA were both considered
as standard of reference for the evaluation of CVST.6 The diagnosis
of CVSTwas made separate using venCTA or venMRA by an indepen-
dent third researcher (W.G.K.).
Statistical Analysis
We performed all statistical analyses using SPSS Statistics 23
(IBM, Armonk, NY). For the comparison of the ratings of diagnostic
confidence and quality of depiction as well as thrombus lengthFIGURE 4. Example of waveletCTA-based exclusion of suspected CVST. A 61-
left-sided hemiparesis. A, In the artCTA, a filling defect (arrowheads) in the lef
additional MRI examination was performed 12 hours later with TOF-venMRA
demonstrates angiographic signal (arrow) in the left sigmoid sinus, representi
306 www.investigativeradiology.com
Copyright © 2017 Wolters Kluwer Hmeasurements, 2-sample t tests were performed. Continuous variables
are reported as mean and standard deviation (SD) in case of normal
distribution and as median and interquartile range (IQR) in case of
nonnormal distribution. Normal distribution was assessed using the
Kolmogorov-Smirnov test. The Likert scale variables are presented as
mean and SD. P values below 0.05 were considered to indicate
statistical significance.RESULTS
The study population consisted of 10 patients with confirmed
CVST and prior WB-CTP imaging, and 6 patients with suspicion of
CVST in the initial artCTA, which was later ruled out by venCTA or
venMRA. The reconstruction of waveletCTAwas technically success-
ful and yielded diagnostic image quality in all 16 patients of the study
population and in all 30 control patients. Detailed patient characteristics
of the study population are shown in Table 1. Patient examples are
shown in Figures 2 to 4.year-old female patient with recent myocardial infarction and acute
t sigmoid sinus was detected, raising the suspicion of CVST. B–D, An
and CE-venMRA, which ruled out CVST (arrows). E, WaveletCTA
ng regular blood flow. VRT indicates volume rendering technique.
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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TABLE 2. Diagnostic Accuracy and Confidence of Multiparametric CT ± WaveletCTA
Location
NECT ArtCTA WaveletCTA VenCTA/VenMRA
Cord Sign Thromb Diag Conf
Length,
mm Thromb Diag Conf
Length,




SSS No Yes 5 55 Yes 5 45 Yes 5 43
Left TRAS and SIGS No Yes 3 138 Yes 3 123 Yes 5 121
Left TRAS and SIGS No Yes 4 110 Yes 4 94 Yes 5 91
Left SIGS No No 5 NA Yes 5 72 Yes 5 75
Left TRAS and SIGS Yes Yes 4 157 Yes 5 162 Yes 5 159
Right SIGS No No 5 NA Yes 4 54 Yes 4 51
Right SIGS No Yes 3 82 Yes 5 71 Yes 5 69
Right TRAS No Yes 3 87 Yes 4 42 Yes 5 44
Right TRAS and SIGS No Yes 5 149 Yes 5 146 Yes 5 148
Left TRAS and SIGS No No 5 NA Yes 5 136 Yes 5 133
ArtCTA-suspected but follow-up–excluded CVST
Right TRAS and SIGS No Yes 3 137 No 5 NA No 5 NA
Left SIGS No Yes 4 72 No 5 NA No 5 NA
Left and right TRAS No Yes 2 35 Yes 2 13 No 5 NA
Left cortical vein No Yes 2 27 No 3 NA No 5 NA
Left TRAS No Yes 2 46 No 5 NA No 5 NA
SSS No Yes 2 31 No 5 NA No 5 NA
CT indicates computed tomography; waveletCTA, wavelet-transformed CTA; NECT, nonenhanced CT; artCTA, arterial CTangiography; venCTA/venMRA, venous
CT/MR angiography; Thromb, thrombosis; Diag Conf, diagnostic confidence; SSS, superior sagittal sinus; TRAS, transverse sinus; SIGS, sigmoid sinus; CVST,
cerebral venous sinus thrombosis; NA, not applicable.
Investigative Radiology • Volume 52, Number 5, May 2017 Wavelet-Based CTA for the Detection of CVSTDiagnostic Value of WaveletCTA in
Follow-up–Confirmed CVST (n = 10)
Of 10 patients with venCTA- or venMRA-confirmed CVST, the
reading of the initial multiparametric CT correctly identified CVST in
7 patients with a mean diagnostic confidence of 3.8/5. The reading
together with the waveletCTA correctly identified all 10 patients with
a mean diagnostic confidence of 4.5/5 (SD, 0.7; overall sensitivity,
100%). The thrombus length measurements yielded similar results
based on waveletCTA compared with venCTA/venMRA (94.5 vs
93.4 mm; SD, 44.3 vs 43.9), indicating that there was no significant
overestimation or underestimation of thrombus burden by waveletCTA
(P = 0.956). The median time delay from initial multiparametric CT
imaging to the final diagnosis of CVST in all 10 patients was 26 hours
(IQR, 0–46). Immediate additional contrast agent administration for
venCTA to rule out CVSTwas performed in 4 of 10 patients. In the
other 6 cases, the median time delay was 46 hours (IQR, 35–136).
The detailed results are shown in Table 2. Analysis of the parametricTABLE 3. Quantitative Thrombus Attenuation and Signal Measurements
Parameter ArtCTA WaveletCTA
Thrombus, mean HU/signal 83.0 1259.2
Flowing blood, mean HU/signal 201.2 122717.8
Flowing blood-to-thrombus ratio, mean 2.6 146.2
*VenCTAwas available in 8 of 10 patients with CVST. A 2-sample t test was used
statistical significance.
CVST indicates cerebral venous sinus thrombosis; artCTA, arterial CT angiograph
HU, Hounsfield units.
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer HCT perfusion maps revealed minor alterations that corresponded to the
territory of venous drainage in 3 patients (see Supplementary Table 1,
Supplemental Digital Content 1, http://links.lww.com/RLI/A301).
Diagnostic Value of WaveletCTA in ArtCTA-Suspected
but Follow-up–Excluded CVST (n = 6) and in the
Control Group Without CVST (n = 30)
Of 6 patients with artCTA-suspected but follow-up–excluded
CVST, the additional reading of waveletCTA correctly classified
5 patients as CVST negative with a mean diagnostic confidence of
4.6/5 (SD, 0.8). In the only case in which waveletCTAwas not able
to rule out CVST, venMRA could identify an atypically appearing
arachnoid granulation and thus exclude CVST. The artCTA-suspected
diagnoses of CVSTwere ruled out by follow-up examinations after a
median time delay of 35 hours (IQR, 15–59). Detailed results are shown
in Table 2. The 30 control patients were all correctly classified as
negative by waveletCTA with a mean diagnostic confidence of 4.9/5in CVST
P




to compare the mean HU/signal values. Bold P values indicate
y; waveletCTA, wavelet-transformed CTA; venCTA, venous CT angiography;
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Kunz et al Investigative Radiology • Volume 52, Number 5, May 2017(SD, 0.3). Taken together with the 16 patients of the study population,
this results in a patient-based specificity of 97.2%.
Quantitative Thrombus Attenuation and Signal
Measurements in CVST
The flowing blood-to-thrombus ratio was significantly higher in
waveletCTA compared with venCTA or artCTA (146.2 vs 5.9 vs 2.6,
each with P < 0.001; measured using mean waveletCTA signal and
mean CTattenuation values, respectively). Detailed results are provided
in Table 3.
Quality of Depiction of Cerebral Veins and Sinuses
Among the 16 patients of the study population and the 30 control
patients, the quality of depiction for all dural venous sinuses as well as
superficial and deep cerebral veins was rated significantly higher for
waveletCTA compared with artCTA overall (4.2 vs 2.6, P < 0.001) as
well as for each section individually (each P < 0.001).When comparing
waveletCTA to venCTA/venMRA, there was no significant difference
in the quality of depiction when considering all venous sections
together (4.2 vs 4.1, P = 0.374). However, the superior sagittal si-
nus (P = 0.036) and the vein of Labbé (P = 0.004) were rated signifi-
cantly higher in waveletCTA. The detailed quality rating results are
presented in Table 4.
Diagnostic Confidence
Among the 16 patients of the study population and the 30 control
patients, the diagnostic confidence of CVST detection was significantly
higher when the readers were additionally provided with waveletCTA
comparedwithmerely reading themultiparametric CT (study population,
4.4 vs 3.6, P = 0.044; control population, 4.8 vs 3.5, P = 0.007).
DISCUSSION
Our study demonstrates the feasibility of wavelet-based
postprocessing of WB-CTP data for the evaluation of cerebral veinsTABLE 4. Quality of Depiction of Cerebral Veins and Sinuses
Section (n = 46) ArtCTA WaveletCTA VenCTA/V
Dural venous sinuses
Superior sagittal sinus 3.3 (±1.0) 4.7 (±0.5) 4.3 (
Inferior sagittal sinus 2.3 (±1.1) 4.3 (±0.6) 4.2 (
Straight sinus 3.4 (±1.1) 4.6 (±0.6) 4.4 (
Cavernous sinus 1.7 (±0.5) 2.5 (±0.7) 2.9 (
Transverse sinus 3.0 (±1.1) 4.5 (±0.6) 4.3 (
Sigmoid sinus 3.1 (±1.0) 4.6 (±0.7) 4.6 (
Superficial cerebral veins
Superior cerebral veins 2.2 (±1.1) 4.2 (±0.6) 4.0 (
Inferior cerebral veins 1.9 (±1.2) 4.0 (±0.9) 3.8 (
Vein of Trolard 2.5 (±1.0) 4.4 (±0.6) 4.1 (
Vein of Labbé 2.4 (±1.2) 4.5 (±0.7) 3.9 (
Deep cerebral veins
Vein of Galen 3.1 (±0.8) 4.4 (±0.7) 4.5 (
Basal vein of Rosenthal 2.3 (±1.1) 4.2 (±0.8) 4.1 (
Internal cerebral veins 3.2 (±1.0) 4.7 (±0.5) 4.5 (
Overall 2.6 (±1.2) 4.2 (±0.9) 4.1 (
*VenCTA or venMRAwere only available for the 16 patients of the study populat
the quality of depiction. Comparison of waveletCTA to venCTAwas performed using
ArtCTA indicates arterial CT angiography; waveletCTA, wavelet-transformed CTA
308 www.investigativeradiology.com
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WB-CTP, the waveletCTA accurately identified all cases of follow-up–
confirmed CVST (n = 10) and accurately demonstrated thrombus bur-
den. The quantitative flowing blood-to-thrombus ratio in waveletCTA
provided a >50-fold increase in contrast compared with artCTA and
an almost 25-fold increase compared with venCTA. WaveletCTA
correctly ruled out the diagnosis in 5 of 6 cases with follow-up–
excluded CVST, which had been suspected on artCTA (n = 6). The
quality of depiction of venous sections in waveletCTA was signifi-
cantly higher compared with artCTA, and at least equal to venCTA/
venMRA.
To our knowledge, this is the first study to assess the value of a
CTP-derived angiography in evaluating CVST. A recent retrospective
study on confirmed CVST in WB-CTP examinations has detected
perfusion abnormalities matching the venous supply territories of the
occluded sinus, but has not focused on postprocessing WB-CTP data
for depiction of the vessels.17 Another study focusing on the use of
the parametric maps of WB-CTP in CVST patients has demonstrated
the predictive value of absolute perfusion parameters like cerebral
blood flow or volume for the clinical outcome.18
In CVST, the wide spectrum of clinical symptoms often impedes
the diagnosis. In a previous study, the median delay between admission
to a hospital and diagnosis of CVSTwas 3 days.7 Importantly, diagnostic
delay was associated with a higher risk of poor outcome.7 Thus, develop-
ing strategies to shorten the time to diagnosis may improve patients'
overall outcome. The median time delay from CTP imaging to the final
diagnosis of CVST in our study was 26 hours, which could have been
avoided by the use of waveletCTA.
The manifold advantages of WB-CTP postprocessing have been
demonstrated in precise depiction of the intracranial arteries equivalent
to artCTA,8,12 in timing-invariant imaging of collateral vessels19 as well
as their facilitated color-coded evaluation in acute ischemic stroke.20
Potentially decision-relevant parameters can be drawn from postprocessed
WB-CTP data, for example, the velocity of collateral filling21 and a close
definition of the thrombus burden,11 potentially supporting the predictionP















ion. All values shown are mean (±SD). A 2-sample t test was used to compare
the available 16 patients. Bold P values indicate statistical significance.
; venCTA/MRA, venous CT/MR angiography.
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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outcomes.22 General benefits of CT perfusion-based angiographic
techniques as compared with artCTA include higher contrast-to-noise
ratios,8 better depiction of peripheral vessels,14 and improved differen-
tiation between arterial and venous vessels.13
However, WB-CTP is not routinely performed in many institu-
tions because of the implied additional radiation exposure,23,24 the lack
of cross-vendor standardization,25,26 or a limited scan coverage.27 This
partly implies a limitation as WB-CTP is not utilized on a larger scale.
Yet, the added value of various postprocessing techniques including
high-quality angiographic techniques may represent an additional
reason to implement WB-CTP. In this context, it is important to re-
member that in acute stroke, CT is the most widely used imaging
technique28 and CT perfusion protocols are generally relatively easy
to implement. It should be noted, however, that waveletCTA provides
a flow-sensitive representation of the WB-CTP data but anatomical
information is partly lost in the process. It should therefore only be
used as a supplement after prior study of the morphology that is
provided by NECT and artCTA.
There are limitations to this study, which need to be taken into
account when interpreting our data. First, this is a very preliminary
clinical evaluation of a small number of patients with confirmed or
suspected CVST. The small sample size reflects the fact that WB-
CTP is generally not performed in patients with a high suspicion of
CVST. However, the excellent performance of waveletCTA compared
with established venous CTA/MRAprotocols and its accurate depiction
of thrombus burden in our study sample are encouraging and warrant
further evaluation of waveletCTA or other angiographic postprocessing
techniques in this respect. Second, our evaluation is prone to selection
bias regarding the study population as this is a retrospective single-
center study and patients were partially included based on findings on
multiparametric CT. Our sample might therefore not represent the aver-
age CVST patient, for example, the mean patient age was significantly
higher in our study population than the average age of CVST manifes-
tation (68 vs 39 years in the International Study on Cerebral Vein and
Dural Sinus Thrombosis).29
In conclusion, waveletCTA is a promising technique that ex-
pands the value of WB-CTP to the evaluation of the cerebral veins
and sinuses. If clinical or radiological suspicion of CVST is raised in
patients recently examined byWB-CTP, waveletCTAmay shorten time
to diagnosis and replace an additional diagnostic workup.
REFERENCES
1. Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and manage-
ment of cerebral venous thrombosis: a statement for healthcare professionals from
the American Heart Association/American Stroke Association. Stroke. 2011;42:
1158–1192.
2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:
1791–1798.
3. Masuhr F, Mehraein S, Einhäupl K. Cerebral venous and sinus thrombosis.
J Neurol. 2004;251:11–23.
4. Palm F, Urbanek C, Wolf J, et al. Etiology, risk factors and sex differences in
ischemic stroke in the Ludwigshafen Stroke Study, a population-based stroke
registry. Cerebrovasc Dis. 2012;33:69–75.
5. Leach JL, Fortuna RB, Jones BV, et al. Imaging of cerebral venous thrombosis:
current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics.
2006;26(suppl 1):S19–S41; discussion S2–S3.
6. Linn J, Ertl-Wagner B, Seelos KC, et al. Diagnostic value ofmultidetector-rowCT
angiography in the evaluation of thrombosis of the cerebral venous sinuses. AJNR
Am J Neuroradiol. 2007;28:946–952.© 2016 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer H7. Ferro JM, Canhao P, Stam J, et al. Delay in the diagnosis of cerebral vein and dural
sinus thrombosis: influence on outcome. Stroke. 2009;40:3133–3138.
8. Smit EJ, Vonken EJ, van der Schaaf IC, et al. Timing-invariant reconstruction for
deriving high-quality CT angiographic data from cerebral CT perfusion data.
Radiology. 2012;263:216–225.
9. Smit EJ, Vonken EJ, Meijer FJ, et al. Timing-invariant CT angiography derived
fromCT perfusion imaging in acute stroke: a diagnostic performance study. AJNR
Am J Neuroradiol. 2015;36:1834–1838.
10. Frölich AM, Psychogios MN, Klotz E, et al. Angiographic reconstructions from
whole-brain perfusion CT for the detection of large vessel occlusion in acute
stroke. Stroke. 2012;43:97–102.
11. Frolich AM, Schrader D, Klotz E, et al. 4D CTangiography more closely defines
intracranial thrombus burden than single-phase CT angiography. AJNR Am J
Neuroradiol. 2013;34:1908–1913.
12. Mendrik AM, Vonken EP, de Kort GA, et al. Improved arterial visualization in
cerebral CT perfusion-derived arteriograms compared with standard CT angi-
ography: a visual assessment study. AJNR Am J Neuroradiol. 2012;33:2171–2177.
13. Havla L, Schneider M, Thierfelder KM, et al. Validation of a method to differen-
tiate arterial and venous vessels in CT perfusion data using linear combinations of
quantitative time-density curve characteristics. Eur Radiol. 2015;25:2937–2944.
14. Havla L, Thierfelder KM, Beyer SE, et al. Wavelet-based calculation of cerebral
angiographic data from time-resolved CT perfusion acquisitions. Eur Radiol.
2015;25:2354–2361.
15. Sourbron S, Biffar AF, IngrischM, et al. PMI0.4: platform for research in medical
imaging. Proc ESMRMB, Antalya (2009). 2009.
16. Klein S, StaringM,Murphy K, et al. Elastix: a toolbox for intensity-basedmedical
image registration. IEEE Trans Med Imaging. 2010;29:196–205.
17. Mokin M, Ciambella CC, Masud MW, et al. Whole-brain computed tomographic
perfusion imaging in acute cerebral venous sinus thrombosis. Interv Neurol. 2016;
4:104–112.
18. Gupta RK, Bapuraj JR, Khandelwal N, et al. Prognostic indices for cerebral ve-
nous thrombosis on CT perfusion: a prospective study. Eur J Radiol. 2014;83:
185–190.
19. Smit EJ, Vonken EJ, van Seeters T, et al. Timing-invariant imaging of collateral
vessels in acute ischemic stroke. Stroke. 2013;44:2194–2199.
20. Thierfelder KM, Havla L, Beyer SE, et al. Color-coded cerebral computed
tomographic angiography: implementation of a convolution-based algorithm
and first clinical evaluation in patients with acute ischemic stroke. Invest
Radiol. 2015;50:361–365.
21. Beyer SE, von Baumgarten L, Thierfelder KM, et al. Predictive value of the veloc-
ity of collateral filling in patients with acute ischemic stroke. J Cereb Blood Flow
Metab. 2015;35:206–212.
22. Thierfelder KM, Sommer WH, Ertl-Wagner B, et al. Prediction of stent-retriever
thrombectomy outcomes by dynamic multidetector CT angiography in patients
with acute carotid T or MCA occlusions. AJNR Am J Neuroradiol. 2016;37:
1296–1302.
23. Runge VM, Aoki S, Bradley WG Jr, et al. Magnetic resonance imaging and com-
puted tomography of the brain-50 Years of innovation, with a focus on the future.
Invest Radiol. 2015;50:551–556.
24. Manniesing R, Oei MT, van Ginneken B, et al. Quantitative dose dependency
analysis of whole-brain CT perfusion imaging. Radiology. 2016;278:190–197.
25. Austein F, Riedel C, Kerby T, et al. Comparison of perfusion CT software to pre-
dict the final infarct volume after thrombectomy. Stroke. 2016;47:2311–2317.
26. Zussman BM, Boghosian G, Gorniak RJ, et al. The relative effect of vendor
variability in CT perfusion results: a method comparison study. AJR Am J
Roentgenol. 2011;197:468–473.
27. Morhard D,Wirth CD, Fesl G, et al. Advantages of extended brain perfusion com-
puted tomography: 9.6 cm coverage with time resolved computed tomography-
angiography in comparison to standard stroke-computed tomography. Invest
Radiol. 2010;45:363–369.
28. Wintermark M, LubyM, Bornstein NM, et al. International survey of acute stroke
imaging used tomake revascularization treatment decisions. Int J Stroke. 2015;10:
759–762.
29. Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus
thrombosis: results of the International Study on Cerebral Vein and Dural Sinus
Thrombosis (ISCVT). Stroke. 2004;35:664–670.www.investigativeradiology.com 309
ealth, Inc. All rights reserved.
